Status:
COMPLETED
Evaluating the Quality of Different Methods of Obtaining Informed Consent
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Healthy Volunteers
Participant Satisfaction
Eligibility:
All Genders
18+ years
Brief Summary
This is a sub-study of a drug development study conducted by Pfizer, Inc. It will evaluate how well people who participate in research studies understand from the study consent form what the purpose o...
Detailed Description
This informed consent study is a sub-study of phase 1 drug development studies conducted by Pfizer International and is designed to evaluate research participant understanding and satisfaction after b...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All willing adults at least 18 years old who come to the Pfizer CRU to consider volunteering for a phase 1 study for which there is a consent sub-study and who are able to read and answer questions in English are eligible to participate in the sub-study. Only adults (over 18 years old) who can provide their own consent will be included. Because the consent forms for Pfizer studies are written in English, the sub-study will only include individuals who can read and answer questions in English.
Exclusion
Key Trial Info
Start Date :
October 16 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 14 2011
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00794729
Start Date
October 16 2008
End Date
September 14 2011
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer New Haven Clinical Research Unit
New Haven, Connecticut, United States, 06510